Abstract
Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1021/acsmedchemlett.0c00346
Journal: ACS medicinal chemistry letters | Publication Date: Jul 9, 2020 |
Citations: 12 |
Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome
Join us for a 30 min session where you can share your feedback and ask us any queries you have